Vincent van Houten
Director of Finance/CFO bij Forbion Capital Partners Management Holding BV
Profiel
Vincent van Houten is currently a Director at Forbion Capital Fund III Coöperatief UA and Oxitope Pharma BV.
He is also the Chief Financial Officer at Forbion Capital Partners Management Holding BV since 2016.
Previously, he worked as the Chief Financial Officer at Biogeneration Management BV.
Actieve functies van Vincent van Houten
Bedrijven | Functie | Begin |
---|---|---|
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Director of Finance/CFO | 01-01-2016 |
Oxitope Pharma BV
Oxitope Pharma BV Pharmaceuticals: MajorHealth Technology Oxitope Pharma BV is a Dutch pharmaceutical start-up founded in 2020 that focuses on discovering and developing medicine for the treatment of inflammatory and cardiovascular diseases caused by oxidative stress. The company is based in Naarden, Netherlands. The Dutch company takes a different approach to the diagnosis and treatment of these diseases by preventing, halting, or reversing acute and chronic diseases driven by oxidized phospholipids. Oxitope Pharma's goal is to enable people to live long and healthy lives. The CEO is John Montana. | Director/Board Member | - |
Forbion Capital Fund III Coöperatief UA
Forbion Capital Fund III Coöperatief UA Financial ConglomeratesFinance Part of Forbion Capital Partners Management Holding BV, Forbion Capital Fund III Coöperatief UA is a private company based in Naarden, Netherlands. The Dutch company provides investment services. | Director/Board Member | - |
Eerdere bekende functies van Vincent van Houten
Bedrijven | Functie | Einde |
---|---|---|
Biogeneration Management BV
Biogeneration Management BV Investment ManagersFinance Biogeneration Management is a venture capital firm, a subsidiary of BioGeneration Holding BV and was founded in 2006. Biogeneration management is headquartered in Naarden. | Director of Finance/CFO | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Finance |
Biogeneration Management BV
Biogeneration Management BV Investment ManagersFinance Biogeneration Management is a venture capital firm, a subsidiary of BioGeneration Holding BV and was founded in 2006. Biogeneration management is headquartered in Naarden. | Finance |
Forbion Capital Fund III Coöperatief UA
Forbion Capital Fund III Coöperatief UA Financial ConglomeratesFinance Part of Forbion Capital Partners Management Holding BV, Forbion Capital Fund III Coöperatief UA is a private company based in Naarden, Netherlands. The Dutch company provides investment services. | Finance |
Oxitope Pharma BV
Oxitope Pharma BV Pharmaceuticals: MajorHealth Technology Oxitope Pharma BV is a Dutch pharmaceutical start-up founded in 2020 that focuses on discovering and developing medicine for the treatment of inflammatory and cardiovascular diseases caused by oxidative stress. The company is based in Naarden, Netherlands. The Dutch company takes a different approach to the diagnosis and treatment of these diseases by preventing, halting, or reversing acute and chronic diseases driven by oxidized phospholipids. Oxitope Pharma's goal is to enable people to live long and healthy lives. The CEO is John Montana. | Health Technology |